Cargando…

A prognosis model for patients with hepatocellular carcinoma and portal vein tumor thrombus following hepatic resection

The present study aimed to identify the risk factors influencing the survival of patients with hepatocellular carcinoma (HCC) affected by portal vein tumor thrombus (PVTT), following hepatic resection, and to establish a prognostic model. Between March 2001 and May 2008, 234 cases of HCC with PVTT t...

Descripción completa

Detalles Bibliográficos
Autores principales: XIAO, CHENG-ZUO, WEI, WEI, GUO, ZHI-XING, LI, SHU-HONG, ZHANG, YONG-FA, WANG, JIA-HONG, SHI, MING, GUO, RONG-PING
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4665632/
https://www.ncbi.nlm.nih.gov/pubmed/26722243
http://dx.doi.org/10.3892/ol.2015.3677
_version_ 1782403606520004608
author XIAO, CHENG-ZUO
WEI, WEI
GUO, ZHI-XING
LI, SHU-HONG
ZHANG, YONG-FA
WANG, JIA-HONG
SHI, MING
GUO, RONG-PING
author_facet XIAO, CHENG-ZUO
WEI, WEI
GUO, ZHI-XING
LI, SHU-HONG
ZHANG, YONG-FA
WANG, JIA-HONG
SHI, MING
GUO, RONG-PING
author_sort XIAO, CHENG-ZUO
collection PubMed
description The present study aimed to identify the risk factors influencing the survival of patients with hepatocellular carcinoma (HCC) affected by portal vein tumor thrombus (PVTT), following hepatic resection, and to establish a prognostic model. Between March 2001 and May 2008, 234 cases of HCC with PVTT that underwent hepatic resection were randomly divided into experimental or validation groups. The association between the clinicopathological factors and disease-free survival (DFS) and overall survival (OS) was analyzed, and the significant factors involved were used to establish a prognostic model, which was then validated. Tumor rupture, number of tumors and macroscopic vascular invasion were observed to be independent risk factors of DFS and OS. In the prognostic model, the DFS and OS of low-, medium- and high-risk patients in the experimental group were observed to be significantly different, compared to those in the validation group. In conclusion, the present study established a prognostic model for patients with HCC affected by PVTT following hepatectomy, and demonstrated that the model may be used to guide the treatment of these patients and predict their prognosis.
format Online
Article
Text
id pubmed-4665632
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher D.A. Spandidos
record_format MEDLINE/PubMed
spelling pubmed-46656322015-12-31 A prognosis model for patients with hepatocellular carcinoma and portal vein tumor thrombus following hepatic resection XIAO, CHENG-ZUO WEI, WEI GUO, ZHI-XING LI, SHU-HONG ZHANG, YONG-FA WANG, JIA-HONG SHI, MING GUO, RONG-PING Oncol Lett Articles The present study aimed to identify the risk factors influencing the survival of patients with hepatocellular carcinoma (HCC) affected by portal vein tumor thrombus (PVTT), following hepatic resection, and to establish a prognostic model. Between March 2001 and May 2008, 234 cases of HCC with PVTT that underwent hepatic resection were randomly divided into experimental or validation groups. The association between the clinicopathological factors and disease-free survival (DFS) and overall survival (OS) was analyzed, and the significant factors involved were used to establish a prognostic model, which was then validated. Tumor rupture, number of tumors and macroscopic vascular invasion were observed to be independent risk factors of DFS and OS. In the prognostic model, the DFS and OS of low-, medium- and high-risk patients in the experimental group were observed to be significantly different, compared to those in the validation group. In conclusion, the present study established a prognostic model for patients with HCC affected by PVTT following hepatectomy, and demonstrated that the model may be used to guide the treatment of these patients and predict their prognosis. D.A. Spandidos 2015-11 2015-09-03 /pmc/articles/PMC4665632/ /pubmed/26722243 http://dx.doi.org/10.3892/ol.2015.3677 Text en Copyright: © Xiao et al. This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs License (https://creativecommons.org/licenses/by-nc-nd/4.0/) , which permits use and distribution in any medium, provided the original work is properly cited, the use is non-commercial and no modifications or adaptations are made.
spellingShingle Articles
XIAO, CHENG-ZUO
WEI, WEI
GUO, ZHI-XING
LI, SHU-HONG
ZHANG, YONG-FA
WANG, JIA-HONG
SHI, MING
GUO, RONG-PING
A prognosis model for patients with hepatocellular carcinoma and portal vein tumor thrombus following hepatic resection
title A prognosis model for patients with hepatocellular carcinoma and portal vein tumor thrombus following hepatic resection
title_full A prognosis model for patients with hepatocellular carcinoma and portal vein tumor thrombus following hepatic resection
title_fullStr A prognosis model for patients with hepatocellular carcinoma and portal vein tumor thrombus following hepatic resection
title_full_unstemmed A prognosis model for patients with hepatocellular carcinoma and portal vein tumor thrombus following hepatic resection
title_short A prognosis model for patients with hepatocellular carcinoma and portal vein tumor thrombus following hepatic resection
title_sort prognosis model for patients with hepatocellular carcinoma and portal vein tumor thrombus following hepatic resection
topic Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4665632/
https://www.ncbi.nlm.nih.gov/pubmed/26722243
http://dx.doi.org/10.3892/ol.2015.3677
work_keys_str_mv AT xiaochengzuo aprognosismodelforpatientswithhepatocellularcarcinomaandportalveintumorthrombusfollowinghepaticresection
AT weiwei aprognosismodelforpatientswithhepatocellularcarcinomaandportalveintumorthrombusfollowinghepaticresection
AT guozhixing aprognosismodelforpatientswithhepatocellularcarcinomaandportalveintumorthrombusfollowinghepaticresection
AT lishuhong aprognosismodelforpatientswithhepatocellularcarcinomaandportalveintumorthrombusfollowinghepaticresection
AT zhangyongfa aprognosismodelforpatientswithhepatocellularcarcinomaandportalveintumorthrombusfollowinghepaticresection
AT wangjiahong aprognosismodelforpatientswithhepatocellularcarcinomaandportalveintumorthrombusfollowinghepaticresection
AT shiming aprognosismodelforpatientswithhepatocellularcarcinomaandportalveintumorthrombusfollowinghepaticresection
AT guorongping aprognosismodelforpatientswithhepatocellularcarcinomaandportalveintumorthrombusfollowinghepaticresection
AT xiaochengzuo prognosismodelforpatientswithhepatocellularcarcinomaandportalveintumorthrombusfollowinghepaticresection
AT weiwei prognosismodelforpatientswithhepatocellularcarcinomaandportalveintumorthrombusfollowinghepaticresection
AT guozhixing prognosismodelforpatientswithhepatocellularcarcinomaandportalveintumorthrombusfollowinghepaticresection
AT lishuhong prognosismodelforpatientswithhepatocellularcarcinomaandportalveintumorthrombusfollowinghepaticresection
AT zhangyongfa prognosismodelforpatientswithhepatocellularcarcinomaandportalveintumorthrombusfollowinghepaticresection
AT wangjiahong prognosismodelforpatientswithhepatocellularcarcinomaandportalveintumorthrombusfollowinghepaticresection
AT shiming prognosismodelforpatientswithhepatocellularcarcinomaandportalveintumorthrombusfollowinghepaticresection
AT guorongping prognosismodelforpatientswithhepatocellularcarcinomaandportalveintumorthrombusfollowinghepaticresection